STORM Therapeutics
Agent34Agent Readiness: 34/100. Below median. Measured by StartupHub.ai. Median 41.Trust57Data Trust: 57/100. Below median. Measured by StartupHub.ai. Median 61.Clinical-stage biotech company targeting RNA modifications for novel cancer therapies.
About
STORM Therapeutics is a clinical-stage biotechnology company focused on developing novel cancer therapies by targeting RNA modifications. Their lead candidate, STC-15, is the first RNA-modifying enzyme inhibitor to enter human clinical trials, specifically inhibiting METTL3, an enzyme crucial for regulating cancer stem cell differentiation. The company aims to reprogram malignant cells and treat diseases, with a current focus on sarcomas and other malignancies.
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Biotechnology company developing and commercializing cell therapies for cancer treatment.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Shares Biotechnology, Pharmaceuticals
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Shares Biotechnology, Oncology
Key facts
- Website
- stormtherapeutics.com
- Headquarters
- Cambridge, England, United Kingdom
- Founded
- 2015
- Total funding
- $51M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Apr 2026 | Series C | $51M |
Tech stack
Detected on stormtherapeutics.com, last scanned 23 Oct 2026. Run your own scan
- Analytics
- Google Analytics 4
- Email provider
- Mimecast
STORM Therapeutics scores 28. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is STORM Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for STORM Therapeutics is 57 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has STORM Therapeutics raised?
STORM Therapeutics has raised a total of $51M in funding. The most recent round on record is Series C.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for STORM Therapeutics
